Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - ACCOUNTS PAYABLE
Accounts Payable YMAB - Y-mAbs Therapeutics, Inc.
6.66 M
LAST VALUE
-31.44%
2 YEAR CAGR
-4.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR